First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.75 EUR -0.72% Market Closed
Updated: May 18, 2024

BRAIN Biotech AG
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BRAIN Biotech AG
Total Liabilities Peer Comparison

Comparables:
WCH
EVK
1COV
ACT
SY1

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Total Liabilities
€46m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Total Liabilities
€4.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Evonik Industries AG
XETRA:EVK
Total Liabilities
€11B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Covestro AG
XETRA:1COV
Total Liabilities
€7.1B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Total Liabilities
€263.1m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Total Liabilities
€4.2B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
13%

See Also

What is BRAIN Biotech AG's Total Liabilities?
Total Liabilities
46m EUR

Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Total Liabilities amounts to 46m EUR.

What is BRAIN Biotech AG's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
2%

Over the last year, the Total Liabilities growth was 5%. The average annual Total Liabilities growth rates for BRAIN Biotech AG have been 1% over the past three years , 2% over the past five years .